Search Results - "WANDERS, Rinus"

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial by Le Péchoux, Cécile, Dr, Dunant, Ariane, MS, Senan, Suresh, Prof, Wolfson, Aaron, Prof, Quoix, Elisabeth, Prof, Faivre-Finn, Corinne, MD, Ciuleanu, Tudor, MD, Arriagada, Rodrigo, Prof, Jones, Richard, MD, Wanders, Rinus, MD, Lerouge, Delphine, MD, Laplanche, Agnès, MD

“…Summary Background The optimum dose of prophylactic cranial irradiation (PCI) for limited-stage small-cell lung cancer (SCLC) is unknown. A meta-analysis…”
Get full text

A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making by Oberije, Cary, Nalbantov, Georgi, Dekker, Andre, Boersma, Liesbeth, Borger, Jacques, Reymen, Bart, van Baardwijk, Angela, Wanders, Rinus, De Ruysscher, Dirk, Steyerberg, Ewout, Dingemans, Anne-Marie, Lambin, Philippe

“…Abstract Background Decision Support Systems, based on statistical prediction models, have the potential to change the way medicine is being practiced, but…”
Get full text

Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review by van Baardwijk, Angela, Tomé, Wolfgang A, van Elmpt, Wouter, Bentzen, Søren M, Reymen, Bart, Wanders, Rinus, Houben, Ruud, Öllers, Michel, Lambin, Philippe, De Ruysscher, Dirk

“…Abstract Background and purpose For stereotactic body radiotherapy (SBRT), typically a scheme of 60 Gy in 3–8 fractions is applied, producing local tumour…”
Get full text

Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer by DE RUYSSCHER, Dirk, PIJIS-JOHANNESMA, Madelon, VANSTEENKISTE, Johan, LAMBIN, Philippe, BENTZEN, Søren M, MINKEN, André, WANDERS, Rinus, LUTGENS, Ludy, HOCHSTENBAG, Monique, BOERSMA, Liesbeth, WOUTERS, Bradly, LAMMERING, Guido

“…To identify time factors for combined chemotherapy and radiotherapy predictive for long-term survival of patients with limited-disease small-cell lung cancer…”
Get full text

Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer by Reymen, Bart, MD, Van Loon, Judith, MD, PhD, van Baardwijk, Angela, MD, PhD, Wanders, Rinus, MD, Borger, Jacques, MD, PhD, Dingemans, Anne-Marie C., MD, PhD, Bootsma, Gerben, MD, PhD, Pitz, Cordula, MD, PhD, Lunde, Ragnar, MD, Geraedts, Wiel, MD, Lambin, Philippe, MD, PhD, De Ruysscher, Dirk, MD, PhD

“…Purpose In non-small cell lung cancer, gross tumor volume (GTV) influences survival more than other risk factors. This could also apply to small cell lung…”
Get full text

Radiation Dose Prescription for Non–Small-Cell Lung Cancer According to Normal Tissue Dose Constraints: An In Silico Clinical Trial by van Baardwijk, Angela, M.D, Bosmans, Geert, M.Sc, Bentzen, Søren M., Ph.D., D.Sc, Boersma, Liesbeth, M.D., Ph.D, Dekker, André, M.Sc., Ph.D, Wanders, Rinus, M.D, Wouters, Bradly G., Ph.D, Lambin, Philippe, M.D., Ph.D, De Ruysscher, Dirk, M.D., Ph.D

“…Purpose Local tumor recurrence remains a major problem in patients with inoperable non–small-cell lung cancer undergoing radiotherapy. We investigated the…”
Get full text

State of the Art Radiation Therapy for Lung Cancer 2012: A Glimpse of the Future by De Ruysscher, Dirk, Belderbos, José, Reymen, Bart, van Elmpt, Wouter, van Baardwijk, Angela, Wanders, Rinus, Hoebers, Frank, Vooijs, Marc, Öllers, Michel, Lambin, Philippe

“…Abstract The prognosis of patients with lung cancer has improved over the past years. Patient selection, optimal sequencing of systemic and local treatments,…”
Get full text

High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL by Pijls-Johannesma, Madelon, Houben, Ruud, Boersma, Liesbeth, Grutters, Janneke, Seghers, Katarina, Lambin, Philippe, Wanders, Rinus, Ruysscher, Dirk De

“…Abstract Background and purpose Aggressive radiotherapy or concurrent chemo-radiation therapy for lung cancer leads to a high incidence of severe, mostly…”
Get full text

The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study by Steenland, Elsbeth, Leer, Jan, van Houwelingen, Hans, Post, Wendy J., van den Hout, Wilbert B., Kievit, Job, de Haes, Hanneke, Martijn, Hendrik, Oei, Bing, Vonk, Ernest, van der Steen-Banasik, Elzbieta, Wiggenraad, Ruud G.J., Hoogenhout, Jaap, Wárlám-Rodenhuis, Carla, van Tienhoven, Geertjan, Wanders, Rinus, Pomp, Jacqueline, van Reijn, M., van Mierlo, Thijs, Rutten, Ewald

“…Purpose: To answer the question whether a single fraction of radiotherapy that is considered more convenient to the patient is as effective as a dose of…”
Get full text

HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Continuous Hyperfractionated Accelerated Radiotherapy in Patients With Inoperable Non–Small-Cell Lung Cancer by De Ruysscher, Dirk, M.D., Ph.D, Wanders, Rinus, M.D, van Haren, Erik, M.D., Ph.D, Hochstenbag, Monique, M.D., Ph.D, Geraedts, Wiel, M.D, Pitz, Cordula, M.D., Ph.D, Simons, Jean, M.D., Ph.D, Boersma, Liesbeth, M.D., Ph.D, Verschueren, Tom, M.D, Minken, Andre, M.Sc., Ph.D, Bentzen, Søren M., M.Sc., Ph.D, Lambin, Philippe, M.D., Ph.D

“…Purpose To determine the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non–small-cell lung cancer…”
Get full text

18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: A planning study by van Loon, Judith, Offermann, Claudia, Bosmans, Geert, Wanders, Rinus, Dekker, André, Borger, Jacques, Oellers, Michel, Dingemans, Anne-Marie, van Baardwijk, Angela, Teule, Jaap, Snoep, Gabriel, Hochstenbag, Monique, Houben, Ruud, Lambin, Philippe, De Ruysscher, Dirk

“…To investigate the influence of selective irradiation of 18FDG-PET positive mediastinal nodes on radiation fields and normal tissue exposure in limited disease…”
Get full text

Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450) by De Ruysscher, Dirk, Wanders, Rinus, van Baardwijk, Angela, Dingemans, Anne-Marie C, Reymen, Bart, Houben, Ruud, Bootsma, Gerben, Pitz, Cordula, van Eijsden, Linda, Geraedts, Wiel, Baumert, Brigitta G, Lambin, Philippe

“…Stage IV non-small-cell lung cancer (NSCLC) patients with oligometastases (< 5 metastatic lesions) may experience long-term survival when all macroscopic tumor…”
Get more information

Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test by Gooding, Mark J., Smith, Annamarie J., Tariq, Maira, Aljabar, Paul, Peressutti, Devis, Stoep, Judith, Reymen, Bart, Emans, Daisy, Hattu, Djoya, Loon, Judith, Rooy, Maud, Wanders, Rinus, Peeters, Stephanie, Lustberg, Tim, Soest, Johan, Dekker, Andre, Elmpt, Wouter

“…Purpose Automated techniques for estimating the contours of organs and structures in medical images have become more widespread and a variety of measures are…”
Get full text

Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study by van Loon, Judith, De Ruysscher, Dirk, Wanders, Rinus, Boersma, Liesbeth, Simons, Jean, Oellers, Michel, Dingemans, Anne-Marie C, Hochstenbag, Monique, Bootsma, Gerben, Geraedts, Wiel, Pitz, Cordula, Teule, Jaap, Rhami, Ali, Thimister, Willy, Snoep, Gabriel, Dehing-Oberije, Cary, Lambin, Philippe

“…To evaluate the results of selective nodal irradiation on basis of (18)F-deoxyglucose positron emission tomography (PET) scans in patients with limited-disease…”
Get full text

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study by De Ruysscher, Dirk, van Baardwijk, Angela, Wanders, Rinus, Hendriks, Lizza E., Reymen, Bart, van Empt, Wouter, Öllers, Michel C., Bootsma, Gerben, Pitz, Cordula, van Eijsden, Linda, Dingemans, Anne-Marie C.

“…•With isotoxic radiotherapy dose escalation given concurrently with chemotherapy in patients with stage III NSCLC, toxicity was indeed as predicted and fairly…”
Get full text

Hypoxia imaging with [18 F]HX4 PET in NSCLC patients: Defining optimal imaging parameters by Zegers, Catharina M.L, van Elmpt, Wouter, Wierts, Roel, Reymen, Bart, Sharifi, Hoda, Öllers, Michel C, Hoebers, Frank, Troost, Esther G.C, Wanders, Rinus, van Baardwijk, Angela, Brans, Boudewijn, Eriksson, Jonas, Windhorst, Bert, Mottaghy, Felix M, De Ruysscher, Dirk, Lambin, Philippe

“…Abstract Background and purpose [18 F]HX4 is a promising hypoxia PET-tracer. Uptake, spatio-temporal stability and optimal acquisition parameters for [18 F]HX4…”
Get full text

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan by Aerts, Hugo J W L, van Baardwijk, Angela A W, Petit, Steven F, Offermann, Claudia, Loon, Judith van, Houben, Ruud, Dingemans, Anne-Marie C, Wanders, Rinus, Boersma, Liesbeth, Borger, Jacques, Bootsma, Gerben, Geraedts, Wiel, Pitz, Cordula, Simons, Jean, Wouters, Bradly G, Oellers, Michel, Lambin, Philippe, Bosmans, Geert, Dekker, Andre L A J, De Ruysscher, Dirk

“…Non-small cell lung cancer (NSCLC) tumours are mostly heterogeneous. We hypothesized that areas within the tumour with a high pre-radiation (18)F-deoxyglucose…”
Get full text

Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR) by Reymen, Bart, van Baardwijk, Angela, Wanders, Rinus, Borger, Jacques, Dingemans, Anne-Marie C, Bootsma, Gerben, Pitz, Cordula, Lunde, Ragnar, Geraedts, Wiel, Lambin, Philippe, De Ruysscher, Dirk

“…Abstract Background Non-small cell lung cancer (NSCLC) stage T4N0-1 or single nodal station IIIA-N2 are two stage III sub-groups for which the outcome of…”
Get full text

Standard of care in high-dose radiotherapy for localized non-small cell lung cancer by De Ruysscher, Dirk, Lambrecht, Maarten, van Baardwijk, Angela, Peeters, Stéphanie, Reymen, Bart, Verhoeven, Karolien, Wanders, Rinus, Öllers, Michel, van Elmpt, Wouter, van Loon, Judith

Get more information

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study by Martinussen, Hanneke M.A, Reymen, Bart, Wanders, Rinus, Troost, Esther G.C, Dingemans, Anne-Marie C, Öllers, Michel, Houben, Ruud, De Ruysscher, Dirk, Lambin, Philippe, van Baardwijk, Angela

“…Abstract Background and purpose Isolated nodal failures (INF) are rare after 3D-conformal radiotherapy (3D-CRT) for stage III non-small cell lung cancer…”
Get full text